Investigational drug · Phase 2
BL0020
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Small Cell Carcinoma of Lung.
Phase 2Last checked: Nov 19, 2026Latest source record: Feb 17, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
3
Any phase or sponsor naming "BL0020"
First trial start
2026
Mar 27, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "BL0020", any sponsor or status.
Conditions studied
As listed on its trial records.
- Small Cell Carcinoma of Lung
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "BL0020" as an intervention, largest first.
- Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid TumorsStatus unknown
Shanghai Best-Link Bioscience, LLCIndustry
NCT05886868 · 66 participants (planned) · Start Oct 24, 2023 · Primary completion Jul 2024
Drug: BL0020 · For: Advanced Solid Tumor
Sites: Sydney, Australia; Birtinya, Australia; Beijing, China · 4 sites in all
Shanghai Best-Link Bioscience, LLCIndustry
NCT07414927 · 48 participants (planned) · Start Mar 27, 2026 · Primary completion Dec 22, 2027
Drug: BL0020 · For: Small Cell Carcinoma of Lung
Sites: Shanghai, China
Shanghai Best-Link Bioscience, LLCIndustry
NCT07550842 · 33 participants (planned) · Start Jun 16, 2026 · Primary completion Apr 28, 2028
Drug: BL0020; Toripalimab · For: Small Cell Carcinoma of Lung
Sites: Harbin, China; Zhengzhou, China; Wuhan, China · 8 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.